Articles on low and middle income countries

Displaying all articles

A new UN-backed initiative is enabling qualified generic manufacturers to develop, produce and supply vital medicines such as antivirals independently. By reducing the cost of essential medicines, pooled licensing particularly benefits low- and middle-income countries, in sub-Saharan Africa, for instance. Maxim Studio/Shutterstock (no reuse)

The Medicines Patent Pool is improving access to essential medication where it’s most needed, but does it make economic sense?

Three economists explore the viability of a UN-backed one-stop licensing ‘hub’ for making essential, often life-saving biotherapeutics and vaccines both affordable and more widely available.
Cancer groundshot highlights that investment in improving access to treatments already proven to work saves more lives than discovery of a new treatment. (Shutterstock)

Cancer groundshot: Access to proven treatments must parallel development of new therapies

Globally, most cancer patients die not because they don’t have access to newer drugs, but because they don’t have access to even basic treatments. Cancer groundshot aims to improve treatment access.
Health-care workers protest over stalled contract negotiations with the provincial government in Montréal in October 2020. THE CANADIAN PRESS/Paul Chiasson

Workers, not warriors: 4 lessons from health worker protests during COVID‑19 that could help avert a looming workforce crisis

To prevent a shortage of health workers, public expressions of appreciation need to be backed by policies that provide dignity, decent working conditions, accountability and appropriate remuneration.

Top contributors

More